HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist

5.010
-0.010-0.20%

Market Closed Dec 12 16:08 CST

58.31BMarket Cap10.20P/E (TTM)

CSPC PHARMA Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Turnover

-4.94%22.69B

1.27%16.28B

11.54%8.98B

1.66%31.45B

1.57%23.87B

3.01%16.08B

2.28%8.05B

11.02%30.94B

13.83%23.5B

12.93%15.61B

Operating income

-4.94%22.69B

1.27%16.28B

11.54%8.98B

1.66%31.45B

1.57%23.87B

3.01%16.08B

2.28%8.05B

11.02%30.94B

13.83%23.5B

12.93%15.61B

Cost of sales

5.26%-6.7B

4.40%-4.63B

1.87%-2.49B

-6.83%-9.27B

-10.29%-7.07B

-13.37%-4.84B

-22.87%-2.53B

-28.95%-8.68B

-28.62%-6.41B

-29.53%-4.27B

Operating expenses

5.26%-6.7B

4.40%-4.63B

1.87%-2.49B

-6.83%-9.27B

-10.29%-7.07B

-13.37%-4.84B

-22.87%-2.53B

-28.95%-8.68B

-28.62%-6.41B

-29.53%-4.27B

Gross profit

-4.80%15.99B

3.71%11.65B

17.70%6.5B

-0.36%22.18B

-1.70%16.79B

-0.89%11.24B

-5.03%5.52B

5.31%22.26B

9.11%17.08B

7.73%11.34B

Selling expenses

5.79%-6.62B

2.55%-4.78B

-18.97%-2.96B

11.58%-9.14B

13.34%-7.03B

9.39%-4.9B

11.91%-2.49B

1.01%-10.34B

-4.32%-8.11B

-1.69%-5.41B

Administrative expenses

-2.88%-880.65M

-18.15%-632.84M

-26.51%-332.83M

-1.43%-1.19B

2.08%-855.97M

5.17%-535.64M

-1.07%-263.08M

-16.14%-1.17B

-16.82%-874.16M

-13.64%-564.82M

Research and development expenses

-5.49%-3.88B

-10.35%-2.54B

-16.04%-1.17B

-21.17%-4.83B

-25.95%-3.68B

-22.27%-2.3B

-11.77%-1.01B

-16.14%-3.99B

-16.43%-2.92B

-16.81%-1.88B

Special items of operating profit

-36.05%259.57M

-19.70%172.47M

41.09%59.06M

-48.38%420.59M

-8.36%405.88M

-13.72%214.78M

164.60%41.86M

49.32%814.85M

-22.03%442.91M

-54.52%248.93M

Operating profit

-13.72%4.86B

4.42%3.87B

16.13%2.09B

-1.82%7.44B

0.27%5.63B

-0.47%3.71B

2.37%1.8B

11.47%7.57B

8.24%5.62B

2.38%3.73B

Financing cost

-97.26%-33.29M

-104.95%-21.98M

-37.84%-6.11M

-4.04%-25.9M

-12.51%-16.88M

-10.29%-10.72M

-54.97%-4.43M

-224.78%-24.89M

-132.70%-15M

-103.22%-9.72M

Share of profits of associates

-19.90%-39.53M

-67.65%-27.24M

-24.61%-15.01M

3.40%-41.07M

29.06%-32.97M

39.72%-16.25M

-42.31%-12.05M

-77.91%-42.51M

-119.94%-46.48M

-38.43%-26.95M

Share of profit from joint venture company

-653.04%-41.44M

-983.37%-24.43M

-187.38%-13.48M

-148.43%-13.13M

-113.24%-5.5M

-108.12%-2.26M

-131.76%-4.69M

-41.49%27.11M

15.51%41.56M

32.14%27.78M

Special items of earning before tax

----

-31.63%32.86M

--32.86M

----

28.64%48.07M

----

Earning before tax

-15.41%4.75B

3.25%3.8B

15.57%2.06B

-2.54%7.39B

0.23%5.61B

-1.02%3.68B

0.97%1.78B

10.74%7.58B

7.18%5.6B

1.54%3.72B

Tax

2.28%-942.7M

-20.23%-749.66M

-37.35%-428.35M

2.48%-1.32B

5.98%-964.74M

9.95%-623.51M

5.39%-311.86M

-16.50%-1.35B

-24.40%-1.03B

-25.03%-692.38M

After-tax profit from continuing operations

-18.13%3.8B

-0.21%3.05B

10.94%1.63B

-2.56%6.07B

1.62%4.65B

1.02%3.06B

2.43%1.47B

9.56%6.23B

3.95%4.57B

-2.64%3.03B

Earning after tax

-18.13%3.8B

-0.21%3.05B

10.94%1.63B

-2.56%6.07B

1.62%4.65B

1.02%3.06B

2.43%1.47B

9.56%6.23B

3.95%4.57B

-2.64%3.03B

Minority profit

-83.53%24.77M

-65.85%31.09M

-57.68%17.04M

41.74%199.37M

45.84%150.38M

49.57%91.05M

35.22%40.26M

69.59%140.66M

66.96%103.11M

30.80%60.88M

Profit attributable to shareholders

-15.94%3.78B

1.80%3.02B

12.88%1.61B

-3.58%5.87B

0.60%4.49B

0.03%2.97B

1.73%1.43B

8.67%6.09B

3.06%4.47B

-3.15%2.97B

Basic earnings per share

-15.35%0.3203

2.24%0.2551

13.51%0.1361

-3.21%0.4947

0.93%0.3784

0.24%0.2495

1.70%0.1199

9.00%0.5111

3.39%0.3749

-2.85%0.2489

Diluted earnings per share

-15.33%0.3203

2.24%0.2551

13.51%0.1361

-3.21%0.4947

0.91%0.3783

0.24%0.2495

1.70%0.1199

9.00%0.5111

3.39%0.3749

-2.85%0.2489

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang Certified Public Accountants

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Turnover	-4.94%22.69B	1.27%16.28B	11.54%8.98B	1.66%31.45B	1.57%23.87B	3.01%16.08B	2.28%8.05B	11.02%30.94B	13.83%23.5B	12.93%15.61B
Operating income	-4.94%22.69B	1.27%16.28B	11.54%8.98B	1.66%31.45B	1.57%23.87B	3.01%16.08B	2.28%8.05B	11.02%30.94B	13.83%23.5B	12.93%15.61B
Cost of sales	5.26%-6.7B	4.40%-4.63B	1.87%-2.49B	-6.83%-9.27B	-10.29%-7.07B	-13.37%-4.84B	-22.87%-2.53B	-28.95%-8.68B	-28.62%-6.41B	-29.53%-4.27B
Operating expenses	5.26%-6.7B	4.40%-4.63B	1.87%-2.49B	-6.83%-9.27B	-10.29%-7.07B	-13.37%-4.84B	-22.87%-2.53B	-28.95%-8.68B	-28.62%-6.41B	-29.53%-4.27B
Gross profit	-4.80%15.99B	3.71%11.65B	17.70%6.5B	-0.36%22.18B	-1.70%16.79B	-0.89%11.24B	-5.03%5.52B	5.31%22.26B	9.11%17.08B	7.73%11.34B
Selling expenses	5.79%-6.62B	2.55%-4.78B	-18.97%-2.96B	11.58%-9.14B	13.34%-7.03B	9.39%-4.9B	11.91%-2.49B	1.01%-10.34B	-4.32%-8.11B	-1.69%-5.41B
Administrative expenses	-2.88%-880.65M	-18.15%-632.84M	-26.51%-332.83M	-1.43%-1.19B	2.08%-855.97M	5.17%-535.64M	-1.07%-263.08M	-16.14%-1.17B	-16.82%-874.16M	-13.64%-564.82M
Research and development expenses	-5.49%-3.88B	-10.35%-2.54B	-16.04%-1.17B	-21.17%-4.83B	-25.95%-3.68B	-22.27%-2.3B	-11.77%-1.01B	-16.14%-3.99B	-16.43%-2.92B	-16.81%-1.88B
Special items of operating profit	-36.05%259.57M	-19.70%172.47M	41.09%59.06M	-48.38%420.59M	-8.36%405.88M	-13.72%214.78M	164.60%41.86M	49.32%814.85M	-22.03%442.91M	-54.52%248.93M
Operating profit	-13.72%4.86B	4.42%3.87B	16.13%2.09B	-1.82%7.44B	0.27%5.63B	-0.47%3.71B	2.37%1.8B	11.47%7.57B	8.24%5.62B	2.38%3.73B
Financing cost	-97.26%-33.29M	-104.95%-21.98M	-37.84%-6.11M	-4.04%-25.9M	-12.51%-16.88M	-10.29%-10.72M	-54.97%-4.43M	-224.78%-24.89M	-132.70%-15M	-103.22%-9.72M
Share of profits of associates	-19.90%-39.53M	-67.65%-27.24M	-24.61%-15.01M	3.40%-41.07M	29.06%-32.97M	39.72%-16.25M	-42.31%-12.05M	-77.91%-42.51M	-119.94%-46.48M	-38.43%-26.95M
Share of profit from joint venture company	-653.04%-41.44M	-983.37%-24.43M	-187.38%-13.48M	-148.43%-13.13M	-113.24%-5.5M	-108.12%-2.26M	-131.76%-4.69M	-41.49%27.11M	15.51%41.56M	32.14%27.78M
Special items of earning before tax	----	----	----	-31.63%32.86M	--32.86M	----	----	28.64%48.07M	----	----
Earning before tax	-15.41%4.75B	3.25%3.8B	15.57%2.06B	-2.54%7.39B	0.23%5.61B	-1.02%3.68B	0.97%1.78B	10.74%7.58B	7.18%5.6B	1.54%3.72B
Tax	2.28%-942.7M	-20.23%-749.66M	-37.35%-428.35M	2.48%-1.32B	5.98%-964.74M	9.95%-623.51M	5.39%-311.86M	-16.50%-1.35B	-24.40%-1.03B	-25.03%-692.38M
After-tax profit from continuing operations	-18.13%3.8B	-0.21%3.05B	10.94%1.63B	-2.56%6.07B	1.62%4.65B	1.02%3.06B	2.43%1.47B	9.56%6.23B	3.95%4.57B	-2.64%3.03B
Earning after tax	-18.13%3.8B	-0.21%3.05B	10.94%1.63B	-2.56%6.07B	1.62%4.65B	1.02%3.06B	2.43%1.47B	9.56%6.23B	3.95%4.57B	-2.64%3.03B
Minority profit	-83.53%24.77M	-65.85%31.09M	-57.68%17.04M	41.74%199.37M	45.84%150.38M	49.57%91.05M	35.22%40.26M	69.59%140.66M	66.96%103.11M	30.80%60.88M
Profit attributable to shareholders	-15.94%3.78B	1.80%3.02B	12.88%1.61B	-3.58%5.87B	0.60%4.49B	0.03%2.97B	1.73%1.43B	8.67%6.09B	3.06%4.47B	-3.15%2.97B
Basic earnings per share	-15.35%0.3203	2.24%0.2551	13.51%0.1361	-3.21%0.4947	0.93%0.3784	0.24%0.2495	1.70%0.1199	9.00%0.5111	3.39%0.3749	-2.85%0.2489
Diluted earnings per share	-15.33%0.3203	2.24%0.2551	13.51%0.1361	-3.21%0.4947	0.91%0.3783	0.24%0.2495	1.70%0.1199	9.00%0.5111	3.39%0.3749	-2.85%0.2489
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks